ALNYLAM PHARMACEUTICALS, INC. Purchase Obligation, to be Paid, Year One
ALNYLAM PHARMACEUTICALS, INC. (ALNY) had Purchase Obligation, to be Paid, Year One of $87.50 million as of 2015-12-31, per its 10-K filed 2016-02-12.
Discontinued › Notes › Commitment and Contingencies › Purchase Obligation, Fiscal Year Maturity
us-gaap:PurchaseObligationDueInNextTwelveMonths · last filed 2016-02-12
- 2015-12-31: Purchase Obligation, to be Paid, Year One $87.50M.
- 2014-12-31: Purchase Obligation, to be Paid, Year One $59.30M.
- 2013-12-31: Purchase Obligation, to be Paid, Year One $33.60M.
- 2012-12-31: Purchase Obligation, to be Paid, Year One $10.30M.
| Period end | Purchase Obligation, to be Paid, Year One |
|---|---|
| 2015-12-31 | $87.50M 10-K · filed 2016-02-12 |
| 2014-12-31 | $59.30M 10-K · filed 2015-02-13 |
| 2013-12-31 | $33.60M 10-K · filed 2014-02-20 |
| 2012-12-31 | $10.30M 10-K · filed 2013-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |